These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14161913)

  • 1. A CONTROLLED COMPARISON OF STREPTOMYCIN PLUS PYRAZINAMIDE AND STREPTOMYCIN PLUS PAS IN THE RETREATMENT OF PATIENTS EXCRETING ISONIAZID-RESISTANT ORGANISMS.
    VELU S; DAWSON JJ; DEVADATTA S; FOX W; KULKARNI KG; MOHAN K; RAMAKRISHNAN CV; STOTT H
    Tubercle; 1964 Jun; 45():144-59. PubMed ID: 14161913
    [No Abstract]   [Full Text] [Related]  

  • 2. TREATMENT OF PATIENTS WITH CULTURES RESISTANT TO THE PRIMARY ANTI-TUBERCULOSIS DRUGS.
    ZIERSKI M
    Tubercle; 1964 Jun; 45():96-100. PubMed ID: 14161919
    [No Abstract]   [Full Text] [Related]  

  • 3. ["PERSISTANCE" OF THE "SENSITIVE" KOCH BACILLI. CLINICO-EXPERIMENTAL STUDY].
    LERNER S
    Rev Esp Tuberc; 1963 Oct; 32():497-505. PubMed ID: 14123028
    [No Abstract]   [Full Text] [Related]  

  • 4. CHEMOTHERAPY OF PREVIOUSLY TREATED PATIENTS WITH PULMONARY TUBERCULOSIS.
    GIUNIO N
    Tubercle; 1964 Sep; 45():202-4. PubMed ID: 14227805
    [No Abstract]   [Full Text] [Related]  

  • 5. CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
    JANCIK E; ZELENKA M; TOUSEK J; MAKOVA M
    Tubercle; 1963 Dec; 44():443-5. PubMed ID: 14101324
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 7. A PRELIMINARY REPORT ON A NEW ANTITUBERCULOUS DRUG 4-AMINO-2-HYDROXY-PHENYL-1, 3, 4,-OXADIAZOL-2-OL WS 127.
    SMITH AE; ASPEVIK E; EVENSTAD E; HAUKENES G
    Acta Tuberc Pneumol Scand; 1964; 45():231-55. PubMed ID: 14234467
    [No Abstract]   [Full Text] [Related]  

  • 8. D-CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS RESISTANT TO THE STANDARD DRUGS: A STUDY OF 116 CASES.
    RUIZ RC
    Dis Chest; 1964 Feb; 45():181-6. PubMed ID: 14115734
    [No Abstract]   [Full Text] [Related]  

  • 9. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 10. RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
    CORPE RF; BLALOCK FA; GROSS JH; GOLDHAMMER EJ
    Am Rev Respir Dis; 1964 Dec; 90():957-60. PubMed ID: 14233802
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 12. ALTERNATING REGIMENS OF STREPTOMYCIN-PYAZINAMIDE, ISONIAZID-PARA-AMINOSALICYLIC ACID AT BATTEY STATE HOSPITAL.
    CORPE RF; BLALOCK FA
    Am Rev Respir Dis; 1964 Aug; 90():262-5. PubMed ID: 14198672
    [No Abstract]   [Full Text] [Related]  

  • 13. [1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
    ZAJACZKOWSKA J; JANCZY S; BURACZEWSKA M; KORLAKOWSKI J; ZYCH D; KRYCHNIAK W
    Gruzlica (1926); 1964 Feb; 32():89-95. PubMed ID: 14136692
    [No Abstract]   [Full Text] [Related]  

  • 14. [COMBINATION OF ETHIONAMIDE AND P-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO ISONIAZID AND STREPTOMYCIN].
    PEREZ JA; FARIAS CE; AMADIO G; CAFURE N
    Prensa Med Argent; 1963 Dec; 50():3280-1. PubMed ID: 14184234
    [No Abstract]   [Full Text] [Related]  

  • 15. PULMONARY TUBERCULOSIS.
    CHAVES AD
    Mod Treat; 1964 Mar; 1():330-59. PubMed ID: 14159591
    [No Abstract]   [Full Text] [Related]  

  • 16. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

  • 17. A STUDY OF THE INFLUENCE OF THE ISONIAZID INACTIVATOR PHENOTYPE ON REVERSION IN GENITO-URINARY TUBERCULOSIS.
    GOW JG; EVANS DA
    Tubercle; 1964 Jun; 45():136-43. PubMed ID: 14161912
    [No Abstract]   [Full Text] [Related]  

  • 18. [BRONCHIAL TUBERCULOSIS AND BACTERIAL RESISTANCE].
    PILHEU JA
    Torax; 1963; 12():163-4. PubMed ID: 14158177
    [No Abstract]   [Full Text] [Related]  

  • 19. [ETHIONAMIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    ZIERSKI M
    G Ital Chemioter; 1963; 10():110-7. PubMed ID: 14074246
    [No Abstract]   [Full Text] [Related]  

  • 20. CONTROLLED CLINICAL TRIAL OF 4-4 DIISOAMYLOXYTHIOCARBANILIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    MOODIE AS; SISTER AQUINAS ; FOORD RD
    Tubercle; 1964 Sep; 45():192-201. PubMed ID: 14227804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.